Overview

• Farmacity has given Bank of America a mandate to evaluate passive investment partners or a possible IPO without altering its ownership structure.
• Executives said the financing drive is aimed at securing capital for expansion in expectation of greater Argentine investment after upcoming elections.
• The company has already poured approximately $2.1 billion into its Simplicity non-pharmacy format and $1.8 billion into a new Córdoba distribution center.
• A recent government rule removing ANMAT from certain import approvals is expected to streamline inbound cosmetics and hygiene products for Farmacity outlets.
• Analysts view the move as a market signal for other domestic firms as the pharmacy sector consolidates under players such as Farmatodo and Central Oeste.